<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="177">
  <stage>Registered</stage>
  <submitdate>11/08/2005</submitdate>
  <approvaldate>26/08/2005</approvaldate>
  <actrnumber>ACTRN12605000221651</actrnumber>
  <trial_identification>
    <studytitle>Propofol induction in cannabis using patients</studytitle>
    <scientifictitle>Dose of Propofol for induction of general anaesthesia in cannabis using patients</scientifictitle>
    <utrn />
    <trialacronym>PICUP</trialacronym>
    <secondaryid>Nil known</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Anaesthesia</healthcondition>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Other anaesthesiology</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>The dose of propofol required to induce general anaesthesia will be compared in cohorts of patients who use cannabis regularly and those who do not use it at all.
The duration of the intervention is 90 seconds, the time required to reach or not reach primary endpoint of unconsciousness.</interventions>
    <comparator>Non-cannabis users</comparator>
    <control>Active</control>
    <interventioncode>None</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>The successful insertion of a laryngeal mask after induction of anaesthesia</outcome>
      <timepoint>60 seconds post-successful induction of anaesthesia</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>The dose of intravenous propofol required to achieve a bispectral index value of less than 60.</outcome>
      <timepoint>post-successful induction of anaesthesia</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>LMA anaesthesia,  ASA 1-2.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>50</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Weight &gt;100kgs, cardiovascular disease, use of opiod,cocaine or amphetamines,benzodiazepine &amp; SSRI use, allergy to propofol,alcohol abuse, anti retro-viral therapy, unstable pre-induction BIS value.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Diagnosis</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Sealed envelope</concealment>
    <sequence>Allocation to one of 5 groups, in blocks within each of the two cohorts of 30. This was achieved by using a computer software randomisation sequence.</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>1/01/2005</anticipatedstartdate>
    <actualstartdate>1/07/2005</actualstartdate>
    <anticipatedenddate>31/12/2007</anticipatedenddate>
    <actualenddate>31/12/2007</actualenddate>
    <samplesize>60</samplesize>
    <actualsamplesize>60</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Dr Per Flisberg</primarysponsorname>
    <primarysponsoraddress>Department of Anaesthesia and Pain Medicine, Royal Perth Hospital, Wellington St Perth WA 6000</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname />
      <fundingaddress />
      <fundingcountry />
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>NIL</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Trial completed and published 2009
Flisberg P, Paech MJ, Shah T, Ledowski T, Kurowski I, Parsons R. Induction dose of propofgol in patients using cannabis. Euro J Anaesthesiol 2009;26:192-5</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Royal Perth Hospital</ethicname>
      <ethicaddress>Royal Perth Hospital Wellington St Perth WA 6000</ethicaddress>
      <ethicapprovaldate>1/04/2005</ethicapprovaldate>
      <hrec>NA</hrec>
      <ethicsubmitdate>31/10/2004</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Mrs</title>
      <name>Shauna Fatovich</name>
      <address>Department of Anaesthesia &amp; Pain Medicine
Royal Perth Hospital 
Wellington Street
Perth WA 6000</address>
      <phone>+61 8 92241036</phone>
      <fax />
      <email>shauna.fatovich@health.wa.gov.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>Michael Paech</name>
      <address>Department of Anaesthesia &amp; Pain Medicine
Royal Perth Hospital 
Wellington Street
Perth WA 6000</address>
      <phone>+61 8 92241036</phone>
      <fax />
      <email>michael.paech@health.wa.gov.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Per Flisberg</name>
      <address>Department of Anaesthesia and Intensive Care, Lund University Hospital, Lund</address>
      <phone>+48 46 17 19 49</phone>
      <fax />
      <email>per.flisberg@skane.se</email>
      <country>Sweden</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>